🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities ! 🎄🌟 🎉
🎄🌟 🎉 Wishing our readers a Merry Christmas and a Happy New Year filled with new possibilities ! 🎄🌟 🎉

NBEC 2022 announces 24 winners with Rs 16 Cr worth cash prizes, investment opportunities

19 December 2022 | News

NBEC is organised every year by the Centre for Cellular and Molecular Platforms

image credit- shutterstock

image credit- shutterstock

The National Bio Entrepreneurship Competition (NBEC) 2022 declares 19 startups/innovators and 5 student teams as winners after an intensely contested four months that attracted ~3000 applications from 35 states and UTs including metros, Tier I, II and III cities.

Now in its 6th year, NBEC is a nationwide annual showcase of India’s most promising business ideas with significant commercial, innovation and impact potentials in the life sciences and biotech domain.

The winners this year addressed challenges in antimicrobial resistance, digital health, therapeutics, medical devices, animal health, agriculture, water and sanitation, food and nutraceuticals, industrial biotechnology, maternal and child nutrition, green chemistry and clean technology.  

Winning startups stand to receive a cumulative of Rs 16 crore in cash prizes and investment opportunities while student-led teams swooped up 9 lakhs in cash prizes over a total of 26 awards declared at the Grand Finale. The competition will provide access to industry mentorship in tie-ups with key industry leaders to selected winners.

NBEC is organised every year by Department of Biotechnology, Govt of India supported organisation, Centre for Cellular and Molecular Platforms (C-CAMP) under the BIRAC Regional Entrepreneurship Centre (BREC), a C-CAMP – BIRAC joint initiative, to attract, identify and nurture year game-changing deep science ideas with business potential. This year it has received support from 30 partners with some of the biggest names in the biotech industry from India.

 

 

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account